Rebalix
Logo Franklin TempletonFranklin Templeton · sheet of 10 September 2026
ETF sheet · official issuer and register data

Franklin ClearBridge US Smaller Companies UCITS ETF

USMID · IE000XJA2OU4 · class SINGLCLASS · USD · domicile Ireland
Equity · United StatesactiveSFDR art. 6
Comparison benchmark: Russell 2500 Growth Index-NR
TER
0.49%+ trans. 0.05%
Fund size
5 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Activeactive management
Income
Accumulating
Launch 29 Oct 2025 · costs from the KID as of 2 Sept 2026 · 92 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Investment Objective To provide long term growth and maximise returns through investment in small and mid-capitalisation companies in the US. Investment Policy The Fund invests in equities of US companies of small and medium market capitalisation. The Investment Manager defines small and mid-capitalisation stocks as those US stocks which fall within a market cap range of $500 million to the largest constituent of the Benchmark at the time of purchase. To a lesser extent, the fund may invest in securities of non-US issuers such as American Depository…

Performance since series start (in euro) — base 100

29 Oct 20258 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202611893108
High 118 (30 Jun 2026) · low 93 (20 Nov 2025) · last 108. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+8.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · USMID · IE000XJA2OU41
RebalixUSMID · IE000XJA2OU4 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 26 Aug 2026 · 92 securities · top-10 weight = 24.0%
Top holdingsWeight
CASH3.4%
RBC BEARINGS INC USD 0.012.5%
CASEY'S GENERAL S USD NPV2.5%
CHARLES RIVER LA USD 0.012.4%
API GROUP CORP USD 0.00012.4%
LATTICE SEMICOND USD 0.012.3%
XPO INC USD 0.0012.2%
ATI Inc USD 0.12.2%
TELEDYNE TECHNOL USD 0.012.2%
RUBRIK INC-A USD 0.0000252.0%
Sectors (% of fund)
Assistenza Sanitaria24.8%Industriali22.7%Tecnologia Informatica22.3%Beni di consumo discrezion…9.3%Finanziari6.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
USMID · Borsa Italiana (ETFplus), Euronext Paris
CBSM · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.franklintempleton.ie/download/en-ie/key-information-document/0bebe
Factsheet · www.franklintempleton.ie/download/en-ie/factsheet/5727f033-be7d-46a6-8
Prospectus · www.franklintempleton.ie/download/en-ie/prospectus/77b538e3-0d06-42a0-
The live sheet, always up to date
rebalix.com/en/etf/IE000XJA2OU4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · USMID · IE000XJA2OU42